¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ°£ÇÐȸ (¿Â¶óÀÎ)Á¦35ȸ Ãá°è Single Topic Symposium : 2022-05-14

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ°£ÇÐȸ (¿Â¶óÀÎ)Á¦35ȸ Ãá°è Single Topic Symposium : 2022-05-14
±³À°ÀÏÀÚ : 2022-05-14
±³À°Àå¼Ò : ¿Â¶óÀÎ °³ÃÖ  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ)Á¦35ȸ Ãá°è Single Topic Symposium 
ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
´ã´çÀÚ : ´ëÇÑ°£ÇÐȸ Áغñ»ç¹«±¹
¿¬¶ôó : 02-373-1005  
À̸ÞÀÏ : kaslsecretariat@hbni.co.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 40,000¿ø      
ºñ°í »çÀüµî·Ï-ȸ¿ø, ÀüÀÓÀÇ, Àü°øÀÇ 30,000¿ø / ºñȸ¿ø, ¿Â¶óÀΠȸ¿ø 40,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 10:10~10:35 Conventional and New Biomarkers for the Management of Chronic Hepatitis B Virus Infection  Marc G. Ghany(National Institute of Health, USA) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 10:35~11:00 Clinical Features of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Chronic Liver Disease  Ju Dong Yang(Cedars-Sinai Medical Center, USA) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 11:00~11:25 Novel Biomarkers for Renal Outcomes in Patients with Liver Cirrhosis  Jasmohan S. Bajaj(Virginia Commonwealth Univ., USA) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 11:25~11:50 Glycemic Control and Non-Alcoholic Fatty Liver Disease Prognosis  Manal F. Abdelmalek(Duke Univ. Medical Center, USA) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:00~13:20 Epidemiology and Natural History of Autoimmune Liver Diseases  Á¤¼÷Çâ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:20~13:40 Pathogenesis of Autoimmune Liver Diseases: Genetics and Environmental Factors  Áø¿µÁÖ(ÀÎÇÏÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:40~14:00 Autoimmune Liver Diseases after Viral Infections Including COVID-19 and Vaccines  ±è°æ¾Æ(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 14:00~14:20 How Do Drugs Trigger Autoimmune Liver Injury?: Immune Checkpoint Inhibitors and Biological Agents  À¯¼öÁ¾(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 14:40~15:00 Diagnosis of Autoimmune Hepatitis and Overlap Syndrome  ¹ÚÁ¤±æ(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 15:00~15:20 Differential Pathologic Features between AIH, PBC and PSC  ÀÌÇý¿ø(°è¸íÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 15:20~15:40 Standard and Emerging Treatments of Autoimmune Liver Disease  ¹Ú¼ö¿µ(°æºÏÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 15:40~16:00 Rescue Therapies for Relapsing and Difficult-To-Treat Autoimmune Liver Disease  ¼ÛÁ¤Àº(´ë±¸°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 12:30~13:00 ÃÊÀ½ÆÄ ±â±â ¼¼Æà ¹æ¹ý  ±èż®(°­¿øÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:00~13:30 Á¤»ó °£ÃÊÀ½ÆÄ ½ºÄµ  ¼ºÇʼö(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:30~14:00 Á¤»ó Ãé´ãµµ ÃÊÀ½ÆÄ ½ºÄµ  °­¹Î±Ô(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 14:00~14:30 °£Áúȯ ¹× Á¾±« ÃÊÀ½ÆÄ ½ºÄµ  ÀÌÀ¯¸²(°æºÏÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ°£ÇÐȸ (¿Â¶óÀÎ)Á¦35ȸ Ãá°è Single Topic Symposium : 2022-05-14""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѾ๰¿µ¾çÀÇÇÐȸ 2022³â Ãá°èÇмú´ëȸ : 2022-05-15
´ÙÀ½±Û ´ëÇѽŰæÁßÀçÄ¡·áÀÇÇÐȸ KSIN Spring symposium & Basic Training Course 2022 : 2022-05-14
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
159 ¼­¿ï ´ëÇѼºÇü¿Ü°úÇÐȸ ±âÃÊÀÇÇבּ¸ È°¼ºÈ­ ¹× Ãʺ¸ÀÚ¸¦ À§ÇÑ ÄÁÆÛ·±½º : 2018-08-31 0 472 2018-07-28
158 ¼­¿ï °í·Á´ëÇб³±¸·Îº´¿ø 1) °áÇÕÁ¶Á÷ Áúȯ 2) ÇǺÎÁö¹æ Áúȯ : 2018-08-30 0 662 2018-07-28
157 ¼­¿ï Çѱ¹³ú½Å°æ°úÇÐȸ Knowing Brain, Healing Brain : 2018-08-30 0 487 2018-07-28
156 ºÎ»ê 2018 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ(8¿ù 30ÀÏ) : 2018-08-30 0 590 2018-07-28
155 ¼­¿ï ´ëÇÑÀÇ»çÇùȸ [Á¦27±â ÀÇ·áÁ¤Ã¥ÃÖ°íÀ§°úÁ¤] 3Â÷ »ó´ë°¡Ä¡ °³Æí : 2018-08-30 0 973 2018-07-28
154 ¼­¿ï ¿øÀڷº´¿ø 2018³âµµ 2Â÷ ¹æ»ç¼±ºñ»óÁø·á ½Å±Ô±³À° (1ÀÏÂ÷) : 2018-08-30 0 921 2018-07-28
153 ºÎ»ê ´ëÇѾȰúÇÐȸ ÇмúÁý´ãȸ(³ì³»Àå, New trends of glaucoma treatment) : 2018-08-30 0 901 2018-07-28
152 °æ±â Çϳ²½Ã ÀÇ»çȸ ¿¬¼ö°­ÁÂ(Ç÷°ü¼ºÄ¡¸Å, °¨¿°³»°ú °¨¿°Áúȯ) : 2018-08-30 0 2,064 2018-07-28
151 ¼­¿ï ÀÎÁ¦´ëÇб³»ó°è¹éº´¿ø °¢¸· Áúȯ : 2018-08-29 0 720 2018-07-28
150 ´ë±¸ ´ë±¸°¡Å縯´ëÇб³º´¿ø Ȳ¹ÝºÎÁ¾ ¹× Ȳ¹Ýº¯¼º : 2018-08-28 0 678 2018-07-28
149 ´ë±¸ ´ëÇѾȰúÇÐȸ 2018³â ´ë±¸ °æºÏ ¾È°ú Áöȸ Á¤±â ¿¬¼ö±³À° : 2018-08-28 0 690 2018-07-28
148 ºÎ»ê ½Å°æ¿µ»óÀÇÇÐÀÇ ÇмúÁõ·Ê¹ßÇ¥ : 2018-08-28 0 308 2018-07-28
147 ºÎ»ê ´ëÇÑÀ忬±¸ÇÐȸ Á¤±âÁý´ãȸ : 2018-08-27 0 561 2018-07-28
146 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø ¼Ò¾ÆÀçÈ°ÀÇÇа­Á : 2018-08-26 0 587 2018-07-28
145 ´ëÀü 2018³â ´ëÇÑÅëÁõÇÐȸ Áö¹æ¼øȸ ÃÊÀ½ÆÄ ¹× °æ¸·¿Ü³»½Ã°æWorkshop_Cadaver Workshop : 2018-08-26 0 661 2018-07-28
1391 | 1392 | 1393 | 1394 | 1395 | 1396 | 1397 | 1398 | 1399 | 1400
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷